SCHEMBL20349968

SCHEMBL20349968

COc1ccc2oc3ccc4cc5c(cc4c3c(=O)c2c1)OCO5

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.58
▸ KDM4E B2RXH2 5/20 0.58
▸ MAPT P10636 4/20 0.58
▸ HPGD P15428 4/20 0.58
▸ NPC1 O15118 4/20 0.58
▸ RAB9A P51151 4/20 0.58
▸ SMN1; SMN2 Q16637 3/20 0.58
▸ CASP3 P42574 1/20 0.58
▸ SENP8 Q96LD8 1/20 0.58
▸ SENP7 Q9BQF6 1/20 0.58
▸ SENP6 Q9GZR1 1/20 0.58
▸ MAOA P21397 2/20 0.52
▸ CYP3A4 P08684 3/20 0.45
▸ CYP2D6 P10635 2/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CTSL P07711 1/20 0.45
▸ CTSB P07858 1/20 0.45
▸ MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20349998 0.91 CYP3A4 (0.55) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL20350032 0.85 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL20349925 0.85 KDM4E (0.75) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL20346674 0.84 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL20346686 0.83 ALPG (0.41) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL20349955 0.83 KDM4E (0.71) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL20346718 0.81 PDE5A (0.43) LMNA
SCHEMBL20346621 0.80 MEN1 (0.52) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL20317343 0.80 NPC1 (0.58) ALDH1A1KDM4EMAPTHPGDNPC1
SCHEMBL5007542 0.79 CASP3 (0.50) ALDH1A1KDM4EMAPTHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180185325-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME THESAN PHARMACEUTICALS, INC. (US) 2018-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180185325-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME AHR, NR1H2, NR1H3 ALDH1A1 1200/4885KDM4E 2074/4885MAPT 2891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback